- Home
- TNXP vs KFFB Comparison
TNXP vs KFFB Comparison
Compare TNXP & KFFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- KFFB
- Stock Information
- Founded
- TNXP 2007
- KFFB 2005
- Country
- TNXP United States
- KFFB United States
- Employees
- TNXP N/A
- KFFB N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- KFFB Savings Institutions
- Sector
- TNXP Health Care
- KFFB Finance
- Exchange
- TNXP Nasdaq
- KFFB Nasdaq
- Market Cap
- TNXP 19.5M
- KFFB 20.7M
- IPO Year
- TNXP N/A
- KFFB 2005
- Fundamental
- Price
- TNXP $0.20
- KFFB $2.60
- Analyst Decision
- TNXP Strong Buy
- KFFB
- Analyst Count
- TNXP 2
- KFFB 0
- Target Price
- TNXP $53.50
- KFFB N/A
- AVG Volume (30 Days)
- TNXP 51.5M
- KFFB 11.6K
- Earning Date
- TNXP 11-12-2024
- KFFB 11-12-2024
- Dividend Yield
- TNXP N/A
- KFFB 15.12%
- EPS Growth
- TNXP N/A
- KFFB N/A
- EPS
- TNXP N/A
- KFFB N/A
- Revenue
- TNXP $11,291,000.00
- KFFB $7,475,000.00
- Revenue This Year
- TNXP $62.53
- KFFB N/A
- Revenue Next Year
- TNXP $26.17
- KFFB N/A
- P/E Ratio
- TNXP N/A
- KFFB N/A
- Revenue Growth
- TNXP 183.05
- KFFB N/A
- 52 Week Low
- TNXP $0.12
- KFFB $2.50
- 52 Week High
- TNXP $22.08
- KFFB $5.06
- Technical
- Relative Strength Index (RSI)
- TNXP 66.43
- KFFB 42.07
- Support Level
- TNXP $0.17
- KFFB $2.56
- Resistance Level
- TNXP $0.28
- KFFB $2.78
- Average True Range (ATR)
- TNXP 0.02
- KFFB 0.15
- MACD
- TNXP 0.01
- KFFB 0.00
- Stochastic Oscillator
- TNXP 44.53
- KFFB 17.86
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company through its subsidiaries is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans and types of deposits, etc. The company mainly operates in Perry, Franklin, Boyle and Garrard and surrounding counties in Kentucky, US.